FDA approved radioactive drugs used by nuclear medicine at the NIH clinical center for patient care procedures.

Ended Indefinite Delivery Contract Awarded Last action

Contract number
75N90023D00003
Awardee
Awarding agency
Task orders
4 $3,235,661 obligated

Award facts

Opportunity
  • 23000138 Solicitation number
Combined order value
$3,235,661 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 83% used
$3,920,000.00
Maximum order
$2,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., was awarded a single-award Indefinite Delivery Contract by the National Institutes of Health Clinical Center on October 1, 2022, with a ceiling value of $3.92 million and an ultimate completion date of September 30, 2026. The contract procures FDA-approved radioactive drugs used in nuclear medicine procedures for patient care at the NIH Clinical Center, a civilian federal healthcare facility that serves as the research hospital for the National Institutes of Health. Cardinal Health 414 specializes in the manufacturing, testing, and distribution of radiopharmaceuticals and medical isotopes from its primary facility in Dublin, Ohio, while maintaining strict compliance with Nuclear Regulatory Commission licensing, FDA approval requirements, and Department of Transportation regulations governing radioactive materials transport. The contract was awarded on an unrestricted basis with no set-aside designation and operates under firm fixed-price structures with economic price adjustment provisions. Performance locations include both the contractor's Dublin, Ohio facility and the NIH Clinical Center in Bethesda, Maryland.

The contract supports the NIH Clinical Center's nuclear medicine and diagnostic imaging operations through the supply of time-sensitive radiopharmaceutical products including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 fluorodeoxyglucose (FDG), and specialized therapeutic agents such as Xofigo for prostate cancer treatment and Lymphoseek for diagnostic imaging. Four delivery orders totaling approximately $2.69 million have been issued under the Indefinite Delivery Contract vehicle, ranging from $362,500 to $993,161 in value, with all orders extending through September 30, 2026. These delivery orders exercise the contract's flexible procurement authority to supply both scheduled routine radiopharmaceutical deliveries and emergency orders, accommodating the stringent delivery requirements—often one to one-and-a-half hours—necessitated by the short half-lives of radioactive isotopes essential for oncology treatment and diagnostic imaging services across the federal healthcare infrastructure.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00007 · Admin modification P00007_75N90023D00003 to extend line item period of performance $0
Exercise an Option P00006 · Modification P00006_75N90023D00003 to exercise option year 3, obligate funding, and increase ceiling limits $0
Other Administrative Action P00005 · P00005 admin. Modification to correct contract ceiling/limit to match modification P00004 value of $3,050,000.00. $0
Other Administrative Action P00004 · P00004 admin. Modification to increase contract ceiling to $3,050,000.00 in preparation for the exercise of option year 2 $0
Exercise an Option P00003 · Exercise option 2 $0
Other Administrative Action P00002 $0
Exercise an Option P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N90023D00003?

75N90023D00003 was awarded to Cardinal Health 414, LLC by NIH Clinical Center (National Institutes of Health) on October 1, 2022.

How much is contract 75N90023D00003 worth?

Orders under 75N90023D00003 have obligated $3,235,661. 75N90023D00003's own ceiling is $3,920,000. A single order can be worth up to $2,000,000.

How many orders have been placed under contract 75N90023D00003?

4 orders have been placed under 75N90023D00003, the latest on October 1, 2022.

Who can order from contract 75N90023D00003?

75N90023D00003 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N90023D00003 competed?

The extent of competition for 75N90023D00003 was not competed. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV